Year: 2023
Type: article
Abstract: . In light of the critical and universal activation of the MAPK pathway in HCC, miR203 has the potential to serve as a nucleotide drug for the treatment of HCC with activated MAPK signaling.
Source: PubMed Central
Authors: Jun Guo, Lei Li, Nan Deng, Yong Xu, Guohua Wang, Hongbo Luo, Chuanrui Xu, Xiaolei Li
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4376224640
